AstraZeneca says Mylan, Kindeva infringe another Symbicort patent
28-04-2022
Roche asks court for halt of Novartis unit’s generic launch
04-04-2022
English court says Roche did not infringe insulin pump patents
13-07-2021
Sundry Photography / Shutterstock.com
Roche’s Chugai and AstraZeneca’s Alexion Pharmaceuticals have brought their patent infringement dispute over a treatment for rare, fatal blood diseases to an end.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Roche, AstraZeneca, Chugai, Alexion Pharmaceuticals, patent infringement, settlement, blood diseases, antigens
